Physician profile
Pascha E Schafer
NPI 1285851360
$2,677.87
in general payments reported to CMS, 2019-2025
18 companies · $676 in 2025
The $676 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $690 · 2020: $145 · 2021: $146 · 2022: $253 · 2023: $358 · 2024: $411 · 2025: $676.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,444.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,444.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $596.73 | 2021-2025 | Micra, Cobalt Dr Mri Surescan, Aurora Ev-Icd Mri Surescan |
| Abiomed | $540.15 | 2019-2024 | Impella |
| Boston Scientific Corporation | $510.83 | 2019-2025 | General - Stents, Synergy, Watchman Flx |
| Medtronic Vascular, INC. | $463.24 | 2019-2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $124.93 | 2020-2025 | Lifevest |
| Astrazeneca Pharmaceuticals LP | $89.51 | 2019 | |
| Shockwave Medical, INC | $59.48 | 2025 | |
| Novartis Pharmaceuticals Corporation | $57.80 | 2025 | |
| Abbott Laboratories | $44.41 | 2023-2025 | Cardiomems, Mitraclip |
| Pfizer INC. | $37.51 | 2025 | |
| Janssen Pharmaceuticals, INC | $26.62 | 2019-2023 | Xarelto |
| Kiniksa Pharmaceuticals International, Plc | $25.84 | 2024 | Arcalyst |
| Heartflow, INC. | $19.66 | 2025 | |
| Teleflex LLC | $19.47 | 2025 | Guideliner |
| Beckman Coulter, INC. | $17.75 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biosense Webster, INC. | $17.00 | 2025 | Carto 3 |
| E.R. Squibb & Sons, L.L.C. | $14.65 | 2025 | Camzyos |
| Cvrx, INC. | $12.29 | 2024 | Barostim Neo System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pascha Schafer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.